News

Alphabet: AI-Supported Growth Story After Reorganization Continues
Alphabet's forward P/E is historically low and 28.11% below Nasdaq's, making it an attractive buy at current levels. Click ...
eWeek5d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Why AI can’t take over creative writing
As a computer scientist, I would hope that human creativity is more than regurgitating what others have written.
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...
Yahoo Finance9d
Is a New AI Model the Catalyst Alphabet Stock Needed?
Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question its position in the artificial intelligence (AI) landscape ...
Fierce Biotech8d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...